Customers looking for an mRNA therapeutic partner should prioritize operational excellence and choose flexible CDMOs.
As we previously discussed, beginning in 2022, a series of patent infringement lawsuits were filed against Moderna and ...
Vietnam Investment Review on MSN18h
AIM Vaccine's mRNA Shingles Vaccine Approved by the US FDA to Begin Clinical Trials, AI-Enabled mRNA Major Vaccine Product Development AcceleratesRecently, AIM announced a comprehensive deployment to integrate the DeepSeek large model, particularly in vaccine development ...
Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...
A vaccine kept patients free of pancreatic cancer for years, yet new reports say the NIH is advising against mentioning mRNA tech in grants.
ZME Science on MSN5d
Finally, mRNA vaccines against cancer are starting to become a realityRNA vaccines were first developed years ago to target cancers and now they're really starting to show promise.
This study shows that RNA decay rather than the presence of premature termination codons triggers a TA-like response.
Officinae Bio's AI-driven sequence optimization expands ... Bio's proprietary digital platform accelerates the prototyping of mRNA drug candidates, enabling the rapid testing of diverse ...
AUSTIN, Texas, February 26, 2025--(BUSINESS WIRE)--ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) ("IPA" or the "Company"), a global leader in AI-powered antibody ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback